ALEXANDRIA, Va., Aug. 24 -- AbbVie, North Chicago, Illinois, and AbbVie Biotherapeutics, Redwood City, California, have been assigned a patent (No. 10,383,948, initially filed March 2, 2018) developed by five co-inventors for "anti-cMet antibody drug conjugates and methods for their use." The co-inventors are Christian B. Allan, San Mateo, California, Mark Anderson, Grayslake, Illinois, Louie Naumovski, Los Altos Hills, California, Edward B. Reilly, Libertyville, California, and Jieyi Wang, Belm . . .